Maine Physical Therapy Limited Partnership | |
23 Leighton Rd, Augusta, ME 04330-7705 | |
(207) 622-5268 | |
(207) 622-7119 |
Full Name | Maine Physical Therapy Limited Partnership |
---|---|
Type | Facility |
Speciality | Clinic/center - Physical Therapy |
Location | 23 Leighton Rd, Augusta, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821106501 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | (* (Not Available)) | Primary |
261QP2000X | Clinic/center - Physical Therapy | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Maine Physical Therapy Limited Partnership 1300 W Sam Houston Pkwy S, Suite 300, Houston, TX 77042-2447 Ph: (713) 297-7000 | Maine Physical Therapy Limited Partnership 23 Leighton Rd, Augusta, ME 04330-7705 Ph: (207) 622-5268 |
News Archive
In a research collaboration blind to affairs of politics, ethnicity, and religion, an international team led by Israeli scientists has identified the genetic cause of a neurological disorder afflicting members of a Palestinian family.
A long-sought goal of creating particles that can emit a colorful fluorescent glow in a biological environment, and that could be precisely manipulated into position within living cells, has been achieved by a team of researchers at MIT and several other institutions. The finding is reported this week in the journal Nature Communications.
The revolution that optogenetics technology has brought to biology - neuroscience in particular - could be transformed all over again if a new project getting underway at Brown University and Central Michigan University is successful.
A team including scientists from The Scripps Research Institute (TSRI), the University of North Carolina at Chapel Hill and the Chinese Academy of Sciences has determined and analyzed the high-resolution atomic structures of two kinds of human serotonin receptor.
Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy. Because the enzyme is not found in most other organisms, including humans, the finding offers insights into how drugs might be created to kill the bacteria without harming humans.
› Verified 2 days ago